Press-release for stocks related to risk for VTRS

Lennox-Gastaut Syndrome Treatment Market 2026, Rising Population With Risk Factors For LGS to Boost Growth - Technavio
Published: 2022-10-06 (Crawled : 02:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

| 32.59% | O: -2.53% H: 0.0% C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M

| 22.55% | O: -0.76% H: 0.44% C: -1.87%
GSK | News | $39.75 1.22% 0.0% 1.6M

| 30.71% | O: -1.25% H: 0.53% C: -0.1%
treatment risk growth market

| -13.68% | O: 22.86% H: 0.0% C: -1.09%
SNYNF | News | $92.7 -2.18% 600K

| -17.18% | O: 3.07% H: 0.0% C: -0.32%
AZNCF | News | $138.24 -4.19% 800

| -3.35% | O: -2.11% H: 0.0% C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M

| 1.9% | O: -0.36% H: 0.18% C: -2.73%
NVS | $94.36 1.93% 0.0% 2.3M

| 1.76% | O: 1.48% H: 0.17% C: -0.37%
GSK | News | $39.75 1.22% 0.0% 1.6M

| -14.05% | O: 1.51% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -16.41% | O: 4.5% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

| -3.64% | O: -0.21% H: 0.41% C: -0.51%
AMGN | $269.03 2.39% 2.33% 3.4M

| 6.71% | O: 0.63% H: 1.91% C: -1.08%
risk therapeutics growth market

| -22.52% | O: 0.0% H: 0.07% C: -1.58%
NVS | $94.36 1.93% 0.0% 2.3M

| 2.76% | O: -0.33% H: 0.26% C: 0.03%
BHC | $8.69 1.05% 0.0% 2.9M

| -69.88% | O: -0.14% H: 0.56% C: -2.46%
epinephrine risk growth